These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Blood plasma pyruvate kinase as a marker of muscular dystrophy. Properties in dystrophic chickens and hamsters. Liu PK; Barnard EA; Barnard PJ Exp Neurol; 1980 Mar; 67(3):581-600. PubMed ID: 7353617 [No Abstract] [Full Text] [Related]
7. Beneficial effect of new thiol protease inhibitors, epoxide derivatives, on dystrophic mice. Komatsu K; Inazuki K; Hosoya J; Satoh S Exp Neurol; 1986 Jan; 91(1):23-9. PubMed ID: 3940877 [TBL] [Abstract][Full Text] [Related]
8. Creatine phosphokinase in cultured control and dystrophic chick embryo muscle. Weinstock IM; Jones KB Biochem Med; 1977 Oct; 18(2):245-55. PubMed ID: 562165 [No Abstract] [Full Text] [Related]
9. Creatine phosphokinase in normal sheep and in sheep with nutritional muscular dystrophy. Boyd JW J Comp Pathol; 1976 Jan; 86(1):23-8. PubMed ID: 1254743 [No Abstract] [Full Text] [Related]
10. The effect of exercise on canine dystrophic muscle. Valentine BA; Blue JT; Cooper BJ Ann Neurol; 1989 Oct; 26(4):588. PubMed ID: 2817833 [No Abstract] [Full Text] [Related]
11. Effect of fasting, phenobarbital, or hydrocortisone on serum creatine-phosphokinase and aldolase activity in myopathic Syrian hamsters. Solymoss B; Jasmin G Proc Soc Exp Biol Med; 1975 Jun; 149(2):491-3. PubMed ID: 1156473 [TBL] [Abstract][Full Text] [Related]
12. Dissociation of creatine kinase activity from hydrolytic enzyme activities in muscle of dystrophic mice. Aoyagi T; Wada T; Kojima F; Nagai M; Harada S; Saito M; Hioki K; Umezawa H Biochem Int; 1985 Oct; 11(4):541-9. PubMed ID: 4084316 [TBL] [Abstract][Full Text] [Related]
13. Pyruvate kinase and creatine phosphokinase during development of the chicken with muscular dystrophy. Weinstock IM; Behrendt JR; Jones KB Life Sci; 1977 Oct; 21(8):1199-205. PubMed ID: 916817 [No Abstract] [Full Text] [Related]
14. A new subline of mice with the mutant gene dystrophia muscularis. Zdorovskaya EP; Lotosh EA; Neifakh SA Sov Genet; 1974 Oct; 8(11):1379-85. PubMed ID: 4445900 [No Abstract] [Full Text] [Related]
15. Pharmocologic therapy of dystrophy in man and animals. Munsat TL Ann N Y Acad Sci; 1979; 317():400-8. PubMed ID: 289320 [No Abstract] [Full Text] [Related]
16. Progressive loss of mitochondrial creatine phosphokinase activity in muscular dystrophy. Mahler M Biochem Biophys Res Commun; 1979 Jun; 88(3):895-906. PubMed ID: 465087 [No Abstract] [Full Text] [Related]
17. The dystrophic murine skeletal muscle cell plasma membrane is structurally intact but "leaky" to creatine phosphokinase. A freeze-fracture analysis. Shivers RR; Atkinson BG Am J Pathol; 1984 Sep; 116(3):482-96. PubMed ID: 6476081 [TBL] [Abstract][Full Text] [Related]
18. Plasma enzyme determinations in normal and dystrophic mice. Morgan J; Shanahan W; Cohen L Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):341-56. PubMed ID: 7221187 [TBL] [Abstract][Full Text] [Related]
19. Muscular dystrophy: inhibition of degeneration in vivo with protease inhibitors. Stracher A; McGowan EB; Shafiq SA Science; 1978 Apr; 200(4337):50-1. PubMed ID: 635570 [TBL] [Abstract][Full Text] [Related]
20. Retardation of symptoms of dystrophy in genetically dystrophic chickens by chemotherapy. Hudecki MS; Barnard EA Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):167-76. PubMed ID: 935649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]